Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
PharmaTalkRadio

PharmaTalkRadio

Pharma Talk Radio

PharmaTalkRadio is an internet radio podcast platform organized and supported by the Conference Forum to give easy and free access to industry professionals, patient advocacy and students in medicine development. PharmaTalkRadio features industry insiders on the latest strategies, business models, and new innovations to advance clinical research with emphasis on clinical trials, patient- centricity, drug delivery, Immuno-oncology, digital, mobile and other technologies as well as leadership topics and emerging biotech challenges. Also featured on PharmaTalkRadio are podcasts covering a wide range of topics from Conference Forum events.
Share icon

All episodes

Best episodes

Seasons

Top 10 PharmaTalkRadio Episodes

Goodpods has curated a list of the 10 best PharmaTalkRadio episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to PharmaTalkRadio for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite PharmaTalkRadio episode by adding your comments to the episode page.

This 7 minute podcast summarizes what you can expect at the 8th annual Immuno-Oncology 360° conference. IO360 ̊convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers. Keynotes include: Dr Gregg Semenza, Johns Hopkins University School of MedicineDr Rachel Haurwitz, Caribou BiosciencesDr Christine Brown, City of HopeDr Suzanne Topalian, Johns Hopkins UniversityDr Andrew Baum, Citi Key topic areas include: Discovery/Preclinical ScienceCell & Gene TherapyTranslational ScienceBispecificsClinical DevelopmentsNeoadjuvant/Adjuvant DataEmerging BiomarkersCytokinesClinical OperationsIO CombinationsImaging AdvancementsBusiness Developments The conference takes place February 16-18, 2022 at the New York Marriott Brooklyn Bridge, New York City, NY. For more information please visit www.io360summit.com or contact us at [email protected]
bookmark
plus icon
share episode
PharmaTalkRadio - 8th annual Mobile in Clinical Trials in 5 Minutes
play

08/04/21 • 6 min

In this podcast, Conference producer, Mark Scherzer, reviews what to expect at the 8th annual Mobile in Clinical Trials conference. The conference will take place September 27, 2021 in Boston, MA also with virtual attendance options. Learn more here.
bookmark
plus icon
share episode
PharmaTalkRadio - HLA Loss and the Impact on Immunotherapy
play

12/27/20 • 21 min

Loss of the HLA locus impairs presentation of tumor antigens and is frequently found in advanced cancers. This talk presented by Dr Lee Albacker, Foundation Medicine and first recorded at the 2020 IO360° Summit, will describe the landscape of HLA loss and other response biomarkers in a dataset of 90,000 solid tumor samples and highlight the effect of HLA loss on checkpoint inhibitor response. To learn more about the upcoming IO360° 2021 Summit please visit www.io360summit.com
bookmark
plus icon
share episode
In this podcast first recorded at the 2020 IO360° Summit, Dr Aiman Shalabi, GSK, moderated a cell and gene therapy debate on intrinsic editing vs systemic combination Participants included: Mark O’Hara, MD, University of PennsylvaniaSaul Priceman, PhD, City of Hope To learn more about the upcoming IO360° 2021 Summit please visit www.io360summit.com
bookmark
plus icon
share episode
In this PharmaTalk podcast, MaryAnne Rizk, PhD, of IQVIA, leads a multi-perspective panel discussion on monitoring in the digital age as data becomes the new currency. Together they discuss how AI and ML are empowering sponsors and sites to predict risk before it happens, how modernization is expanding remote monitoring capabilities and the waterfall impact of that on analytical roles, and how this technology can be leveraged to benefit patient engagement and data standards. Dr Rizk went into deeper detail on this subject at the 2020 DPHARM: Disruptive Innovations conference. Moderator: MaryAnne Rizk, Ph.D. - SVP Digital R&D, IQVIA Guests: Michael Mittleman – Patient Advocate Ray Reilly – VP, Clinical Operations, TG TherapeuticsRajneesh Patil – Head, Process, Technology & Analytics, IQVIA For more information about PharmaTalk podcasts, visit theconferenceforum.org. A special thanks to the team at IQVIA for their support in presenting this podcast.
bookmark
plus icon
share episode
This podcast presents a session on planning for and addressing missing data form the 2019 Mobile in Clinical Trials conference. When a protocol dictates a set period of time for data collection, what happens when there's a gap in the data due to technical glitches or human error? What are the regulatory and operational implications? Discussion points include: How to prepare for missing dataHow do we handle missing data?How to rewrite protocols so that you avoid the trapForewarning and communicating with regulatorsRegulatory advice on how to address missing data Moderator: Jennifer Goldsack, MBA, Executive Director, Digital Medicine Society (DiMe) Panelists: Ariel Dowling, PhD, Associate Director of Digital Clinical Devices, Data Sciences Institute, Takeda Pharmaceuticals Marie McCarthy, MBA, Senior Director of Product Innovation, Information Technology, ICON plc Carrie Northcott, PhD, Project Team Lead, Early Clinical Development, Digital Medicine, Pfizer Shyamal Patel, PhD, Director of Data Science, Digital Medicine & Translational Imaging, Pfizer The 2020 Mobile in Clinical Trials event will take place on September 21. Learn more here.
bookmark
plus icon
share episode
In this podcast, first recorded at the 2nd annual Drug Delivery West conference, Dr James Cunningham, Allergan leads a panel on exploring other routes of administration for ophthalmology. Discussion points include: Barries/challenges associated with drug delivery to the back of the eyeProlonging delivery & reducing frequency of administrationAlternative/less invasive routes of administration for delivery to the back of the eyeDelivery for emerging modalitiesImpact of delivery system design choices on development/scalabilityHow to effectively assess novel delivery approaches Panelists include: Dr James E Chastain, Novartis Institutes for BioMedical Research, IncDr Susan Crowell, GenentechDr Viral Kansara, Clearside Bio To learn more about the 3rd annual Drug Delivery West conference happening May 17-18, 2021 in San Francisco, CA please visit www.drugdeliverywest.org
bookmark
plus icon
share episode
This 5 minute podcast summary helps prepare listeners on what they can expect at the4th Annual Patients as Partners Europe event, taking place January 27th and 28th in London. The venue is the Millennium Gloucester Hotel. In a nutshell, Patient as Partners is the first conference in Europe dedicated to understanding how working with patients can drive greater clinical trial efficiencies throughout the entire medicines development process. It is ultimately about how to reduce risk in the development of hugely, costly clinical trials through working with patients. It is a wonderful opportunity for pharma and biotech and patient disease advocacy groups to come together and learn from each other. The 2020 Summit is chaired by Claire Nolan, of Charities Research Involvement Group, GSK’s Andrew Garvey and Parexel’s Rosamund Round. Our patient keynote guest is Lesley Gosden. Lesley is a Parkinson’s patient and advocate who participated in the GDNF clinical trial, which was featured on the BBC. For more information, visit the conferenceforum.org.
bookmark
plus icon
share episode
In this podcast from the 2018 Mobile in Clinical Trials conference, Dr Paul Glimcher, Julius Silver Professor of Neural Science and Physiology at NYU alongside Dr Daniel Karlin, CEO at Healthmode presented on the future of mobile data in clinical trials. Drs Glimcher and Karlin discussed this rapidly evolving space with an emphasis on the barriers and opportunities in the mobile health arena. More specifically: • What are the Barriers to gathering an incorporating Mobile data into clinical trials? • What are the most important new datatypes that are evolving in the Mobile Health space? • How can we use Real World Measurements to identify new classes of clinically relevant endpoints to go beyond Billing Codes? • Can we expect to see large-scale Mobile databases for synthetic use on the model of EMRs and ICD codes? • How should we think of these new classes of data, are they just novel bioindicators or something else? Dr Karlin is returning to Mobile 2019 as co-chair. Speakers: Paul Glimcher, PhD, Julius Silver Professor of Neural Science and Physiology, NYU Daniel Karlin, MD, CEO, Healthmode
bookmark
plus icon
share episode
About This Episode: What is the future of drug delivery for patients, and how do we get there? In this episode, Dr Shawn Davis, who leads the Drug Delivery team of the Biopharmaceuticals Development organization at AstraZeneca, lays out a bold vision discussing how the future of drug delivery is patients interacting less with their disease, and what steps we can take to make that future a reality. Key Takeaways: How companies can de-risk drug delivery innovationsHow the current moment in drug delivery is shaping our long-term visionBalancing the competitive landscape, portfolio and patient needs About the Speaker: Shawn Davis, PhD is an Executive Director at AstraZeneca and leads the Drug Delivery team of the Biopharmaceuticals Development organization. The team improves patients’ lives by ensuring AZ’s therapies are as safe, effective, and convenient as possible using technologies that target the delivery of medicines to the site of action and optimizing their effective half-life. This requires the evaluation, development, and commercialization of drug delivery technologies across a wide range of modalities in the biopharmaceutical space. Areas of program delivery include: intracellular delivery of nucleic acids, controlled release of antibodies for less frequent dosing, novel routes of administration for therapeutic benefit, and co-delivery of multiple therapeutic molecules. Dr Davis also serves as the CMC leader for early stage assets in the portfolio. For more information about drug delivery, click here.
bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does PharmaTalkRadio have?

PharmaTalkRadio currently has 462 episodes available.

What topics does PharmaTalkRadio cover?

The podcast is about Biotech, Podcasts, Science and Pharmaceutical.

What is the most popular episode on PharmaTalkRadio?

The episode title 'How CMOs Can Evaluate Potential Outsourcing Partners Effectively' is the most popular.

What is the average episode length on PharmaTalkRadio?

The average episode length on PharmaTalkRadio is 28 minutes.

How often are episodes of PharmaTalkRadio released?

Episodes of PharmaTalkRadio are typically released every day.

When was the first episode of PharmaTalkRadio?

The first episode of PharmaTalkRadio was released on Aug 12, 2013.

Show more FAQ

Toggle view more icon

Comments